Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

  • There is currently no data for ALGW

Shareholder Information Update

27 Apr 2022 07:00

RNS Number : 4518J
Alpha Growth PLC
27 April 2022
 

 

 

Alpha Growth Plc

("Alpha", or the "Company")

 

Shareholder Information Update

 

Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services specialist in the growing longevity asset class, it is very pleased to provide the following shareholder information update.

 

Publication of Annual Report

 

In line with other listed companies, Alpha Growth will publish its annual report before the end of the FCA extended period of the end of June, as opposed to April as previously announced. The FCA provided this UK wide extension to ensure companies and their advisors could deliver quality audited financials despite any absences which they may have suffered due to the impact of covid.

 

This allows the Company and its corporate and subsidiary auditors, PKF and KPMG respectively, to provide the IFRS framework accounts in a timely manner.

 

All accounting and audit work is progressing as expected and we look forward to publishing our annual report before the extended deadline.

 

The Company will announce the date for the annual general meeting at or shortly after publishing its annual report and expects to hold an in-person meeting.

 

Shareholder communications

 

In support of our previous commitment to bolster communications with existing shareholders, as well as attract an additional new cohort of shareholders to the Company, we are currently creating a range of videos and presentations which will provide more insight into Alpha's offerings as well as our future growth strategy.

 

We expect these videos and presentations to be published next month.

 

For more information, please visit www.algwplc.com or contact the following:

 

Alpha Growth Plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman 

info@algwplc.com

Arden Partners plc

+44 (0) 20 7614 5900

Ruari McGirr / Alexandra Campbell-Harris (Corporate Finance)

UK Investor Relations - Mark Treharne

ir@algwplc.com

 

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth Group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

 

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

 

Forward Looking Statements Disclaimer

Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward- looking statements, which speak only as of the date of this document. Readers should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their own assessments concerning these and other consequences, including the merits of information and the risks. Readers of this announcement are advised to conduct their own due diligence and agree to be bound by the limitations of this disclaimer.

 

Important Notice

The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDDGDSDXDDGDL
Date   Source Headline
28th Sep 20227:00 amRNSAppointment as Investment Manager/Insurance Update
12th Sep 20222:06 pmRNSSecond Price Monitoring Extn
12th Sep 20222:00 pmRNSPrice Monitoring Extension
9th Sep 20222:06 pmRNSSecond Price Monitoring Extn
9th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSDirector and Personnel Announcement
3rd Aug 20227:00 amRNSHolding(s) in Company
26th Jul 20224:40 pmRNSSecond Price Monitoring Extn
26th Jul 20224:35 pmRNSPrice Monitoring Extension
20th Jun 20224:03 pmRNSResults of the Annual General Meeting
31st May 20227:00 amRNSRelease of 2021 Annual Report
27th Apr 20227:00 amRNSShareholder Information Update
24th Mar 20224:41 pmRNSSecond Price Monitoring Extn
24th Mar 20224:36 pmRNSPrice Monitoring Extension
24th Mar 20222:05 pmRNSSecond Price Monitoring Extn
24th Mar 20222:00 pmRNSPrice Monitoring Extension
24th Mar 20227:00 amRNSAcquisition and Insurance Business Update
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
7th Mar 202211:06 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSBusiness Update - 2022 Focus and the 2B Plan
21st Feb 20227:00 amRNSAppointment of new Strategic Advisor
2nd Feb 20227:00 amRNSBlackOak Alpha Growth Fund 2021 Year End Results
20th Dec 20217:00 amRNSPublication of a Prospectus
17th Dec 20217:00 amRNSChange of Adviser
13th Dec 20216:14 pmRNSHolding(s) in Company
29th Oct 202112:00 pmRNSInterim Results for Extension in Accounting Period
2nd Sep 20214:41 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:35 pmRNSPrice Monitoring Extension
12th Aug 20214:40 pmRNSSecond Price Monitoring Extn
12th Aug 20214:35 pmRNSPrice Monitoring Extension
19th Jul 20214:40 pmRNSSecond Price Monitoring Extn
19th Jul 20214:35 pmRNSPrice Monitoring Extension
19th Jul 20217:00 amRNSTrading Update Q2 2021
6th Jul 20218:00 amRNSChange of Year End
16th Jun 20217:00 amRNSClarification of News
15th Jun 202111:05 amRNSSecond Price Monitoring Extn
15th Jun 202111:00 amRNSPrice Monitoring Extension
15th Jun 20219:05 amRNSSecond Price Monitoring Extn
15th Jun 20219:00 amRNSPrice Monitoring Extension
7th Jun 20217:00 amRNSHolding(s) in Company
7th Jun 20217:00 amRNSWarrants Exercise and Admission Date
2nd Jun 20217:00 amRNSHolding(s) in Company
28th May 20214:00 pmRNSInterim Results
19th May 20217:00 amRNSExercise of Warrants and Total Voting Rights
14th May 20217:00 amRNSHolding(s) in Company
13th May 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.